机译:Rituximab用于治疗自身免疫性血小板功能障碍:两种收购的Glanzmann血栓其症的描述和一种获得的Delta储存池病
Unità Malattie Emorragiche e TromboticheFondazione Policlinico Universitario Agostino Gemeli;
Centro Trombosi e Malattie EmorragicheHumanitas Clinical and Research Centre IRCCSRozzano (Mi) Italy;
Department of Immunohaematology and Transfusion MedicineHospital Papa Giovanni XXIIIBergamo Italy;
Centro Trombosi e Malattie EmorragicheHumanitas Clinical and Research Centre IRCCSRozzano (Mi) Italy;
Rare Blood Disease CentreSanto Spirito HospitalPescara Italy;
Department of Immunohaematology and Transfusion MedicineHospital Papa Giovanni XXIIIBergamo Italy;
Istituto di Medicina Interna e GeriatriaUniversità Cattolica del Sacro CuoreRoma Italy;
Department of Immunohaematology and Transfusion MedicineHospital Papa Giovanni XXIIIBergamo Italy;
Centro Trombosi e Malattie EmorragicheHumanitas Clinical and Research Centre IRCCSRozzano (Mi) Italy;
Unità Malattie Emorragiche e TromboticheFondazione Policlinico Universitario Agostino Gemeli;
acquired platelet function disorders; Glanzmann thrombasthenia; delta storage pool disease; immune‐mediated platelet disorder; rituximab;
机译:Rituximab用于治疗自身免疫性血小板功能障碍:两种收购的Glanzmann血栓其症的描述和一种获得的Delta储存池病
机译:获得的Glanzmann的血栓发球菌:血小板聚集混合研究诊断
机译:获得的Glanzmann的血栓发球菌:血小板聚集混合研究诊断
机译:在患有髓细胞增强综合征的患者中获得了Glanzmann血栓血管瘤
机译:获得性利妥昔单抗耐药性与对化疗的交叉耐药性相关,而硼替佐米治疗可以克服这种交叉耐药性。
机译:与他莫昔芬疗法相关的血小板获得性贮水池紊乱
机译:Rituximab用于治疗自身免疫性血小板功能障碍:两种收购的Glanzmann血栓其症的描述和一种获得的Delta储存池病